Reported Standalone quarterly numbers for HIL are: Net Sales at Rs 534.10 crore in March 2024 up 4.33% from Rs. 511.94 crore in March 2023. Quarterly Net Profit at Rs. 4.06 crore in March 2024 down 72.77% from Rs. 14.91 crore in March 2023. EBITDA stands at Rs. 26.56 crore in March 2024 down 30.09% from Rs. 37.99 crore in March 2023. HIL EPS has decreased to Rs. 5.38 in March 2024.
Open Flip
Tracking subdued global market cues gold prices on MCX for June futures contracts fell by Rs 96 or 0.13% to trade at Rs 72,884 per 10 grams on Friday. Meanwhile, MCX July silver contracts fell by Rs 145 or 0.17% to Rs 87,155 per kg.Traders reconsidered interest rates following Federal Reserve comments about the need for further inflation reduction.
Open Flip
Biocon Ltd's fourth-quarter revenue was mostly in-line with street estimates. The key highlight of the quarter was core biosimilar sales at $282 million, growing by 10% quarter-on-quarter driven by market share gains across molecules. On Friday, shares of Biocon opened a percent higher and were nearing their 52-week high levels of ₹321.20.
Open Flip
